Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol
NCT ID: NCT03517358
Last Updated: 2020-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
10 participants
INTERVENTIONAL
2018-01-01
2018-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy
NCT03570918
Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV
NCT00084032
A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients
NCT00046332
A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials
NCT00075062
A Study of CI-1012 in HIV-Infected Patients
NCT00002196
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pharmacy
service of care: pharmacy
Service of care
Subjects will be receiving care from case management or clinical pharmacy.
Case management
service of care: case management
Service of care
Subjects will be receiving care from case management or clinical pharmacy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Service of care
Subjects will be receiving care from case management or clinical pharmacy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who agree to program enrollment
* Patients ≥ 18 years of age
Exclusion Criteria
* Adults unable to consent
* Prisoners
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
One Community Health
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1150661
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.